Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy NATWEST GROUP (NWG) by Shore Capital
- Hold Central Asia Metals (CAML) by Canaccord Genuity
- Buy Oxford Metrics (OMG) by Canaccord Genuity
- Buy Atalaya Mining (ATYM) by Canaccord Genuity
- Hold BHP Group Limited NPV (DI) (BHP) by Berenberg
- Buy Taseko Mines Limited NPV (DI) (TKO) by Canaccord Genuity
- Underperform AB Dynamics (ABDP) by Jefferies
- Buy AstraZeneca (AZN) by Stifel
- Buy QinetiQ Group (QQ.) by John Fieldsend in The Motley Fool
- Hold Antofagasta (ANTO) by Canaccord Genuity
- Hold Reckitt Benckiser Group (RKT) by Deutsche Bank
- Hold London Stock Exchange Group (LSEG) by Deutsche Bank
- Hold AstraZeneca (AZN) by Deutsche Bank
- Reduce Convatec Group (CTEC) by Peel Hunt
- Hold Fresnillo (FRES) by Berenberg
- Buy Greggs (GRG) by Berenberg
- Overweight WH Smith (SMWH) by Barclays
- Overweight AstraZeneca (AZN) by Barclays
- Buy Barclays (BARC) by Berenberg
- Hold Dr. Martens (DOCS) by HSBC
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 22 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 2.80p | Latest Ask : 2.90p |
| High Today : 2.90p | Low Today : 2.85p |
| This Years High : 6.25p | This Years Low : 0.88p |
| Volume : 342,946 | MKT Cap : £138.21M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -26.09% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -20.83% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | 27.50% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 81.88% |
| Corporate | FinnCap | Premium Only | 2020-03-04 10:50:00 04/03/2020 | – |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 2.80p | Latest Ask : 2.90p |
| High Today : 2.90p | Low Today : 2.85p |
| This Years High : 6.25p | This Years Low : 0.88p |
| Volume : 342,946 | MKT Cap : £138.21M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -26.09% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -20.83% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | 27.50% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 81.88% |
| Corporate | FinnCap | Premium Only | 2020-03-04 10:50:00 04/03/2020 | – |